<DOC>
	<DOCNO>NCT02278471</DOCNO>
	<brief_summary>In study investigator examine effect polypill medication adherence , systolic blood pressure , LDL cholesterol 12 month span .</brief_summary>
	<brief_title>The SCCS Polypill Pilot Trial</brief_title>
	<detailed_description>The purpose study ass polypill-based approach primary CVD prevention feasible low socioeconomic status population . The study ass whether polypill approach associate well cardiovascular risk factor control compare usual care . The polypill supply compound pill contain atorvastatin 10 mg , amlodipine 2.5 mg , losartan 25 mg , hydrochlorothiazide 12.5 mg . The medication polypill extensively evaluate individually combination . Each medication polypill approve United States Food Drug Administration ( FDA ) widely administer US treatment prevention cardiovascular disease . The dos component medication include polypill low , minimize chance potential side-effects . In study assess medication adherence , systolic blood pressure , LDL cholesterol 12 month span , subject take polypill versus subject usual care .</detailed_description>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Enrolled SCCS site Mobile , Alabama , obtain care Franklin Primary Health Center , live surround area . Aged 4575 year Baseline systolic blood pressure ≥120 mm Hg . History coronary heart disease stroke History cancer , except basal cell skin cancer History liver disease laboratory evidence hepatic dysfunction ( alanine aminotransferase level two time upper limit normal range ) Known renal disease , estimate creatinine clearance &lt; 60 Current use 2 antihypertensive medication LDL cholesterol ≥190 mg/dl Insulindependent diabetes Known intolerance component polypill Potassium &lt; 3.4 &gt; 5.5 mEq/L Use medication interact statin , include affect cytochrome P450 system Current use diuretic indication hypertension Comorbidities might expect limit lifespan 12month followup period Inability provide consent .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>combination pill</keyword>
	<keyword>polypill</keyword>
	<keyword>primary prevention</keyword>
</DOC>